CAS 444805-28-1: Hexadecyloxypropyl-cidofovir
Formula:C27H52N3O7P
InChI:InChI=1S/C27H52N3O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-35-20-16-21-37-38(33,34)24-36-25(23-31)22-30-18-17-26(28)29-27(30)32/h17-18,25,31H,2-16,19-24H2,1H3,(H,33,34)(H2,28,29,32)/t25-/m0/s1
InChI key:InChIKey=WXJFKKQWPMNTIM-VWLOTQADSA-N
SMILES:C([C@H](OCP(OCCCOCCCCCCCCCCCCCCCC)(=O)O)CO)N1C(=O)N=C(N)C=C1
Synonyms:- Phosphonic acid, [[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, mono[3-(hexadecyloxy)propyl] ester
- Phosphonic acid, P-[[(1S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]-, mono[3-(hexadecyloxy)propyl] ester
- CMX 001
- HDP-cidofovir
- Hexadecyloxypropyl-cidofovir
Sort by
Found 7 products.
Brincidofovir
CAS:Brincidofovir (HDP-CDV) is an orally active, lipophilic form of cidofovir.Formula:C27H52N3O7PPurity:98% - 99.62%Color and Shape:SolidMolecular weight:561.69Brincidofovir
CAS:Formula:C27H52N3O7PPurity:(HPLC) ≥ 98.0%Color and Shape:White to off-white powderMolecular weight:561.69CMX 001 - Bio-X ™
CAS:Brincidofovir is a lipid prodrug of cidofovir which is used in the treatment of smallpox infections. It is an antiviral drug and inhibits viral replication by inhibiting viral DNA polymerase and viral RNA synthesis. Brincidofovir is part of our Bio-X ™ Range. These products are aimed at life science researchers who need high quality ready-to-use products for assay development, screening or other R&D work. With a solubility datasheet and convenient vials, all of our Bio-X ™ products are in stock across our global warehouses for rapid delivery and ease of use.Formula:C27H52N3O7PPurity:Min. 95%Color and Shape:PowderMolecular weight:561.69 g/molBrincidofovir
CAS:Controlled ProductApplications Brincidofovir is an antiviral inhibitor, working against BK polymavirus replication in primary human urothelial cells. Cytostatic, cytotoxic agent. References Tylden, G. et al.: Antimicrob. Agent. Chemother., 59, 3306 (2015); Cardile, A. et al.: Recent Patents Anti-Infect. Drug DIscov., 9, 97 (2014)Formula:C27H52N3O7PColor and Shape:NeatMolecular weight:561.69CMX 001
CAS:CMX 001 is an antiviral medication that is a prodrug of cidofovir, which is derived from nucleoside analogs with direct inhibition of viral DNA polymerase. This mechanism of action allows CMX 001 to effectively disrupt viral replication by integrating into viral DNA and halting its synthesis. Designed to target a broad range of DNA viruses, this drug offers a robust means of controlling viral infections. Originally developed to combat smallpox and other orthopoxvirus infections, CMX 001 has demonstrated efficacy in treating several other viral diseases, including adenovirus, cytomegalovirus (CMV), and herpesviruses. Its unique formulation allows for oral administration, a notable advantage over intravenous options like cidofovir, which expands its utility in both clinical and emergency settings. The specificity and effectiveness of CMX 001 make it a valuable asset in antiviral therapy, providing an option for treatment-resistant viral strains due to its potent antiviral properties. It represents a significant advancement in the management of viral infections and serves as a critical tool in addressing public health emergencies related to viral outbreaks.Formula:C27H52N3O7PPurity:Min. 98 Area-%Color and Shape:PowderMolecular weight:561.69 g/mol
